| Specificity |
This product is specific to BNIP1 |
| Host Species |
Rabbit |
| Immunogen |
A synthesized peptide derived from human BNIP1 |
| Species Reactivity |
Human; Mouse; Rat |
| Conjugate |
Unconjugated |
|
Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. |
| Application |
Recommended Usage |
| Western Blot |
1:1000-1:2000 |
| Immunohistochemistry (IHC) |
1:100-1:200 |
|
| Form |
Liquid |
| Storage Buffer |
Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions |
Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification |
Affinity-chromatography |
| Isotype |
Rabbit IgG |
| Clonality |
Monoclonal |
| Target Background |
SNARE that may be involved in targeting and fusion of Golgi-derived retrograde transport vesicles with the ER. Required for maintenance of ER network. Implicated in the suppression of cell death. |
| Synonyms |
BCL2 adenovirus E1B 19kD interacting protein 1; BNIP1; Nip1; sec20; SEC20L; Transformation-related gene 8 protein; TRG8; Vesicle transport protein SEC20; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
